AP NEWS

Attention Deficit Hyperactivity Disorder (ADHD): Global Epidemiology and Patient Flow Analysis, 2018-2026 - ResearchAndMarkets.com

June 11, 2018

DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The “Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.

The research provides insights into Attention Deficit Hyperactivity Disorder epidemiology, Attention Deficit Hyperactivity Disorder diagnosed patients, and Attention Deficit Hyperactivity Disorder treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Attention Deficit Hyperactivity Disorder derived from epidemiological analysis, patients diagnosed with Attention Deficit Hyperactivity Disorder, and patients treated with a drug therapy.

The research study helps executives estimate Attention Deficit Hyperactivity Disorder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Attention Deficit Hyperactivity Disorder prevalence, Attention Deficit Hyperactivity Disorder diagnosis rate, and Attention Deficit Hyperactivity Disorder treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features

Attention Deficit Hyperactivity Disorder Patient Flow Attention Deficit Hyperactivity Disorder Prevalence Attention Deficit Hyperactivity Disorder Diagnosed Patients Attention Deficit Hyperactivity Disorder Treated Patients

Key Topics Covered

1. Attention Deficit Hyperactivity Disorder: Disease Definition

2. Global Attention Deficit Hyperactivity Disorder Patient Flow

2A. Global Attention Deficit Hyperactivity Disorder Prevalence

2B. Global Attention Deficit Hyperactivity Disorder Diagnosed Patients

2C. Global Attention Deficit Hyperactivity Disorder Treated Patients

3. Attention Deficit Hyperactivity Disorder Patient Flow in the US

3A. Attention Deficit Hyperactivity Disorder Prevalence in the US

3B. Attention Deficit Hyperactivity Disorder Diagnosed Patients in the US

3C. Attention Deficit Hyperactivity Disorder Treated Patients in the US

4. Attention Deficit Hyperactivity Disorder Patient Flow in Europe

4A. Attention Deficit Hyperactivity Disorder Prevalence in Europe

4B. Attention Deficit Hyperactivity Disorder Diagnosed Patients in Europe

4C. Attention Deficit Hyperactivity Disorder Treated Patients in Europe

5. Attention Deficit Hyperactivity Disorder Patient Flow in Germany

5A. Attention Deficit Hyperactivity Disorder Prevalence in Germany

5B. Attention Deficit Hyperactivity Disorder Diagnosed Patients in Germany

5C. Attention Deficit Hyperactivity Disorder Treated Patients in Germany

6. Attention Deficit Hyperactivity Disorder Patient Flow in France

6A. Attention Deficit Hyperactivity Disorder Prevalence in France

6B. Attention Deficit Hyperactivity Disorder Diagnosed Patients in France

6C. Attention Deficit Hyperactivity Disorder Treated Patients in France

7. Attention Deficit Hyperactivity Disorder Patient Flow in Spain

7A. Attention Deficit Hyperactivity Disorder Prevalence in Spain

7B. Attention Deficit Hyperactivity Disorder Diagnosed Patients in Spain

7C. Attention Deficit Hyperactivity Disorder Treated Patients in Spain

8. Attention Deficit Hyperactivity Disorder Patient Flow in Italy

8A. Attention Deficit Hyperactivity Disorder Prevalence in Italy

8B. Attention Deficit Hyperactivity Disorder Diagnosed Patients in Italy

8C. Attention Deficit Hyperactivity Disorder Treated Patients in Italy

9. Attention Deficit Hyperactivity Disorder Patient Flow in UK

9A. Attention Deficit Hyperactivity Disorder Prevalence in UK

9B. Attention Deficit Hyperactivity Disorder Diagnosed Patients in UK

9C. Attention Deficit Hyperactivity Disorder Treated Patients in UK

10. Attention Deficit Hyperactivity Disorder Patient Flow in Japan

10A. Attention Deficit Hyperactivity Disorder Prevalence in Japan

10B. Attention Deficit Hyperactivity Disorder Diagnosed Patients in Japan

10C. Attention Deficit Hyperactivity Disorder Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/q3qmp2/attention_deficit?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180611006262/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Mental Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/11/2018 05:43 PM/DISC: 06/11/2018 05:43 PM

http://www.businesswire.com/news/home/20180611006262/en

AP RADIO
Update hourly